Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,936 | -13,846 | -175,239 | -40,905 | -27,439 |
| Depreciation Amortization | 10,146 | 5,479 | 142,466 | 17,228 | 11,999 |
| Income taxes - deferred | -1,014 | -557 | 11,466 | 10,964 | -8,418 |
| Accounts receivable | -1,393 | 1,484 | 2,388 | 7,596 | 19,658 |
| Accounts payable and accrued liabilities | 1,596 | -245 | -6,896 | -7,025 | -4,447 |
| Other Working Capital | 2,325 | 4,908 | 2,841 | -7,390 | 3,785 |
| Other Operating Activity | 22,827 | 10,043 | 49,977 | 31,602 | 6,692 |
| Operating Cash Flow | $11,551 | $7,266 | $27,003 | $12,070 | $1,830 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -98,756 | -100,291 | -491,914 | 33,289 | 8,310 |
| PPE Investments | -16,725 | -3,798 | -21,432 | -18,661 | -13,760 |
| Net Acquisitions | N/A | N/A | -399 | N/A | N/A |
| Sale Of Investment | 75,599 | 56,903 | 552,643 | N/A | N/A |
| Investing Cash Flow | $-39,882 | $-47,186 | $38,898 | $14,628 | $-5,450 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,502 | -900 | -4,996 | -3,021 | -1,262 |
| Common Stock Issued | N/A | N/A | 3 | 3 | 3 |
| Common Stock Repurchased | -2,451 | -1,907 | -27,792 | -3,816 | -1,101 |
| Other Financing Activity | 0 | 0 | -15,000 | -15,000 | -15,000 |
| Financing Cash Flow | $-3,953 | $-2,807 | $-47,785 | $-21,834 | $-17,360 |
| Exchange Rate Effect | -78 | -69 | -149 | -294 | -178 |
| Beginning Cash Position | 97,473 | 97,473 | 79,506 | 79,506 | 79,506 |
| End Cash Position | 65,111 | 54,677 | 97,473 | 84,076 | 58,348 |
| Net Cash Flow | $-32,362 | $-42,796 | $17,967 | $4,570 | $-21,158 |
| Free Cash Flow | |||||
| Operating Cash Flow | 11,551 | 7,266 | 27,003 | 12,070 | 1,830 |
| Capital Expenditure | -17,000 | -4,056 | -22,207 | -19,101 | -14,178 |
| Free Cash Flow | -5,449 | 3,210 | 4,796 | -7,031 | -12,348 |